Market Closed -
Hong Kong S.E.
01:38:20 14/05/2024 pm IST
|
5-day change
|
1st Jan Change
|
0.32
HKD
|
0.00%
|
|
+1.59%
|
-8.57%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
166.5
|
150.1
|
143.4
|
119.3
|
120.8
|
152.7
|
Enterprise Value (EV)
1 |
53.11
|
1.739
|
-6.067
|
-32.77
|
-25.66
|
57.49
|
P/E ratio
|
6.82
x
|
5.57
x
|
6.5
x
|
10.2
x
|
10.5
x
|
7.23
x
|
Yield
|
2.53%
|
2.86%
|
2.82%
|
3.28%
|
3.51%
|
5.71%
|
Capitalization / Revenue
|
0.94
x
|
0.85
x
|
0.9
x
|
0.67
x
|
0.47
x
|
0.82
x
|
EV / Revenue
|
0.3
x
|
0.01
x
|
-0.04
x
|
-0.18
x
|
-0.1
x
|
0.31
x
|
EV / EBITDA
|
2.05
x
|
0.05
x
|
-0.24
x
|
-2.26
x
|
-0.93
x
|
2.39
x
|
EV / FCF
|
-2.69
x
|
0.07
x
|
-5.47
x
|
-4.85
x
|
1.82
x
|
1.27
x
|
FCF Yield
|
-37.2%
|
1,420%
|
-18.3%
|
-20.6%
|
54.8%
|
78.4%
|
Price to Book
|
0.68
x
|
0.56
x
|
0.51
x
|
0.41
x
|
0.4
x
|
0.68
x
|
Nbr of stocks (in thousands)
|
4,80,000
|
4,80,000
|
4,80,000
|
4,80,000
|
4,80,000
|
4,80,000
|
Reference price
2 |
0.3468
|
0.3128
|
0.2988
|
0.2485
|
0.2517
|
0.3181
|
Announcement Date
|
25/04/19
|
24/04/20
|
21/04/21
|
19/04/22
|
21/04/23
|
22/04/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
177.1
|
175.8
|
159.9
|
177.3
|
257.2
|
186.1
|
EBITDA
1 |
25.92
|
35.33
|
25
|
14.53
|
27.52
|
24.03
|
EBIT
1 |
23.34
|
32.12
|
20.61
|
9.913
|
22.22
|
18.67
|
Operating Margin
|
13.18%
|
18.28%
|
12.89%
|
5.59%
|
8.64%
|
10.03%
|
Earnings before Tax (EBT)
1 |
25.94
|
34.41
|
23.22
|
12.9
|
26.2
|
25.19
|
Net income
1 |
22.97
|
26.95
|
22.05
|
11.66
|
11.46
|
21.12
|
Net margin
|
12.97%
|
15.33%
|
13.79%
|
6.57%
|
4.46%
|
11.35%
|
EPS
2 |
0.0509
|
0.0561
|
0.0459
|
0.0243
|
0.0239
|
0.0440
|
Free Cash Flow
1 |
-19.73
|
24.7
|
1.109
|
6.754
|
-14.07
|
45.1
|
FCF margin
|
-11.14%
|
14.05%
|
0.69%
|
3.81%
|
-5.47%
|
24.24%
|
FCF Conversion (EBITDA)
|
-
|
69.9%
|
4.44%
|
46.49%
|
-
|
187.7%
|
FCF Conversion (Net income)
|
-
|
91.65%
|
5.03%
|
57.93%
|
-
|
213.53%
|
Dividend per Share
2 |
0.008782
|
0.008939
|
0.008420
|
0.008147
|
0.008846
|
0.0182
|
Announcement Date
|
25/04/19
|
24/04/20
|
21/04/21
|
19/04/22
|
21/04/23
|
22/04/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
113
|
148
|
149
|
152
|
146
|
95.2
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-19.7
|
24.7
|
1.11
|
6.75
|
-14.1
|
45.1
|
ROE (net income / shareholders' equity)
|
13.1%
|
10.5%
|
7.99%
|
4.07%
|
3.88%
|
8.03%
|
ROA (Net income/ Total Assets)
|
6.82%
|
7.08%
|
4.28%
|
2%
|
4.19%
|
3.85%
|
Assets
1 |
337
|
380.4
|
515
|
584.2
|
273.4
|
549.2
|
Book Value Per Share
2 |
0.5100
|
0.5600
|
0.5900
|
0.6000
|
0.6300
|
0.4700
|
Cash Flow per Share
2 |
0.2300
|
0.3100
|
0.3000
|
0.3200
|
0.3100
|
0.2000
|
Capex
1 |
14.7
|
14.9
|
4.84
|
1.08
|
3.42
|
7.3
|
Capex / Sales
|
8.29%
|
8.48%
|
3.03%
|
0.61%
|
1.33%
|
3.92%
|
Announcement Date
|
25/04/19
|
24/04/20
|
21/04/21
|
19/04/22
|
21/04/23
|
22/04/24
|
|
1st Jan change
|
Capi.
|
---|
| -8.57% | 19.66M | | +16.91% | 66.22B | | +2.89% | 49.24B | | +16.50% | 41.4B | | +21.48% | 26.62B | | +13.36% | 19.84B | | +2.79% | 17.44B | | -6.24% | 15.92B | | -23.54% | 15.57B | | +2.12% | 15.45B |
Other Specialty Chemicals
|